Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from In Reply to Onal and Elmali. Local targets link to admitted publications; unresolved targets remain external evidence.
Letter to the editor: Stereotactic ablative radiation therapy for oligoprogressive metastatic RCC: Predictors of prolonged benefit from ongoing systemic therapy. In regard to Zhao et al
2026 · External reference
Stereotactic ablative radiation therapy for oligoprogressive metastatic RCC: Predictors of prolonged benefit from ongoing systemic therapy
10.1016/j.ijrobp.2026.02.215 · 2026 · External reference
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
10.1007/s12094-022-02793-z · 2022 · External reference
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: A multi-institutional study
10.1007/s00066-022-02026-w · 2023 · External reference
